Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dolutegravir in Pregnant HIV Mothers and Their Neonates

NCT03249181 is registered in ClinicalTrials.gov with University of Liverpool as lead sponsor.

NCT NCT03249181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03249181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dolutegravir in Pregnant HIV Mothers and Their Neonates
Lead sponsor
University of Liverpool
Phase
Phase 3
Overall status
Completed
Start date
January 22, 2018
Completion date
September 5, 2023
Enrollment
268 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection, pregnancy related